// App-Quantinova.ai

OC1.6 : Modified GRAS score for prognostic classification of adrenocortical carcinoma: an ENSAT multicentre study

Researchers

Presenter

  • Yasir Elhassan

Principal Investigators

  • Sarah Berhane

  • Harriet Cook

  • Jerome Bertherat

  • Maria Fragoso

  • Darko Kastelan

  • Massimo Terzolo

  • Anna Calabrese

  • Alfredo Berruti

  • Deborah Cosentini

  • Marta Lagan

  • Paola Loli

  • Eric Baudin

  • Harm Haak

  • Letizia Canu

  • Magalie Haissaguerre

  • Otilia Kimpel

  • Jon Deeks

  • Wiebke Arlt

  • Rossella Lib

  • Martin Fassnacht

  • Cristina Ronchi

Medical Centers

  • Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom

  • Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, Würzburg, Germany

  • Test Evaluation Research Group (TERG), Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom

  • Reference Center for Rare Adrenal Cancer (COMETE), Cochin Hospital, Paris, France

  • Unidade de Suprarrenal da Disciplina de Endocrinologia e Metabologia da Faculdade de Medicina da, Universidade de São Paulo, São Paulo, Brazil

  • Departement of Ophtalmology, University Hospital Centre Zagreb, Zagreb, Croatia

  • University of Turin, Department. of Clinical and Biological Sciences, San Luigi Hospital, Orbassano, Italy

  • Medical Oncology, University of Brescia, Spedali Civili Hospital, Brescia, Italy

  • Clinica Polispecialistica San Carlo, via Ospedale 21, Paderno Dugnano, Milano, Italy

  • Nuclear Medicine and Endocrine Oncology, Gustave Roussy Cancer Center, Paris, France

  • Department of Internal Medicine Máxima MC, Eindhoven, Netherlands

  • Department of Experimental and Clinical Biomedical Sciences Mario Serio, University of Florence, Firenze, Italy

  • Service d’Endocrinologie - Diabète et Nutrition CHU de Bordeaux, Bordeaux, France

  • Department of Endocrinology and Metabolic Diseases, Hôpital Cochin, Paris, France

Locations

  • United Kingdom

  • Germany

  • France

  • Brazil

  • Croatia

  • Italy

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Adrenal carcinoma

Biomarkers

  • Acetyl-CoA carboxylase

  • Proliferation marker protein Ki-67

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved